Showing results (1-10 of 500) with videos related to
Sort By:
Pageof 50
Chemmedchem|April 11, 2016
Multitarget Drug Discovery and PolypharmacologyMaria Laura Bolognesi, Andrea CavalliMolecules (Basel, Switzerland)|April 13, 2016
Navigating the Chemical Space of Multitarget-Directed Ligands: From Hybrids to Fragments in Alzheimer's DiseaseFederica Prati, Andrea Cavalli, Maria Laura BolognesiNeurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|December 27, 2008
Memoquin: a multi-target-directed ligand as an innovative therapeutic opportunity for Alzheimer's diseaseMaria Laura Bolognesi, Andrea Cavalli, Carlo MelchiorreJournal of Medicinal Chemistry|July 28, 2017
BACE-1 Inhibitors: From Recent Single-Target Molecules to Multitarget Compounds for Alzheimer's DiseaseFederica Prati, Giovanni Bottegoni, Maria Laura Bolognesi, et al.Bioorganic & Medicinal Chemistry Letters|March 21, 2008
Synthesis of a small library of 2-phenoxy-1,4-naphthoquinone and 2-phenoxy-1,4-anthraquinone derivatives bearing anti-trypanosomal and anti-leishmanial activityMaria Laura Bolognesi, Federica Lizzi, Remo Perozzo, et al.Chembiochem : a European Journal of Chemical Biology|October 17, 2007
Insight into the kinetic of amyloid beta (1-42) peptide self-aggregation: elucidation of inhibitors' mechanism of actionManuela Bartolini, Carlo Bertucci, Maria Laura Bolognesi, et al.FEMS Immunology and Medical Microbiology|October 23, 2009
Complementary medicinal chemistry-driven strategies toward new antitrypanosomal and antileishmanial lead drug candidatesAndrea Cavalli, Federica Lizzi, Salvatore Bongarzone, et al.Journal of Medicinal Chemistry|November 13, 2004
Design, synthesis, and biological evaluation of conformationally restricted rivastigmine analoguesMaria Laura Bolognesi, Manuela Bartolini, Andrea Cavalli, et al.Bioorganic & Medicinal Chemistry Letters|May 6, 2009
Privileged structure-guided synthesis of quinazoline derivatives as inhibitors of trypanothione reductaseAndrea Cavalli, Federica Lizzi, Salvatore Bongarzone, et al.Journal of Medicinal Chemistry|December 13, 2006
Multitarget-directed drug design strategy: a novel molecule designed to block epidermal growth factor receptor (EGFR) and to exert proapoptotic effectsAlessandra Antonello, Andrea Tarozzi, Fabiana Morroni, et al.Pageof 50